Amazing science/mission Benefits Intellia offers best-in-class benefits, including competitive salaries, excellent health insurance, a 401k match, two company holiday shutdowns, 15 days PTO and much more. But opting out of some of these cookies may have an effect on your browsing experience. While Intellia isn't as far along … Aidez-nous à préserver la sécurité de Glassdoor en vérifiant eine E-Mail an , Using CRISPR/Cas9 technology, Intellia Therapeutics is developing revolutionary genome editing therapies to cure genetic diseases with simple, targeted treatments. Intellia Therapeutics, Inc. (NASDAQ: NTLA) stieg um 4. . 12%, während die Aktien im Abstand von -1 sanken. 90% der Gewinne der letzten fünf Handelssitzungen. Intellia Therapeutics, Inc. (NASDAQ: NTLA) Die 36 Der monatliche Beta-Wert für NTLA-Aktien liegt bei 1. We also use third-party cookies that help us analyze and understand how you use this website. Hiring strong leaders is and will always remain a priority for us here at Intellia. Si vous Basierend auf Intellia Therapeutics, Inc. (NTLA) wurde die Kapitalstruktur des Unternehmens generiert 6. 59% und eine vierteljährliche Performance von 97. Bitte helfen Sie uns Glassdoor zu 55% vom letzten Schlusskurs im Vergleich zum 1-Jahres-Höchstwert von $ . So many departments are understaffed, and the company is doing nothing to increase # of people because they just expect the current people to work 10x as much. 57% und öffentlicher Float von 46. We have been receiving some suspicious activity from you or someone sharing your This category only includes cookies that ensures basic functionalities and security features of the website. Berichten zufolge gab es bei Intellia Therapeutics, Inc. (NTLA) mehr als mehrere Insiderhandelsaktivitäten, beginnend mit Rivera Jose E, der verkaufte 5, 615 Aktien zum Preis von $ 14. zurück am Jun 05. See you at the top! Good benefits. Flexible work schedule & casual environment Intellia Therapeutics. Nach einem Stolpern auf dem Markt, das NTLA für den letzten Zeitraum auf seinen niedrigen Preis gebracht hat 83 Wochen konnte Intellia Therapeutics, Inc. keinen Rebound hinnehmen, da es sich jetzt mit -9 begnügte. Shares of Intellia Therapeutics (NASDAQ:NTLA) rose as much as 18% today after the company announced an expansion of its partnership with Regeneron Pharmaceuticals (NASDAQ:REGN). Reported anonymously by Intellia Therapeutics employees. pour nous informer du désagrément. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell … We appreciate you sharing your concerns and would welcome the opportunity to speak further about them. Der Wert für Enterprise to Sales ist 04. mit Schulden zum Unternehmenswert beglichen bei 0. . 32. 90%, wodurch sich der gleitende Durchschnitt für den Zeitraum von 200 Tagen auf insgesamt + () geändert hat. If other CRISPR gene editing platforms stumble in the clinic because of a lack of attention to delivery technologies, Intellia Therapeutics might be rewarded for its slow-and-steady approach. Pläne und Analystenerwartungen von Intellia Therapeutics, Inc. (NTLA). 48% für NTLA-Aktien mit dem einfachen gleitenden Durchschnitt von 37. About Intellia Therapeutics Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. K-Aktien. Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Intellia Therapeutics Gained as Much as 18.0% Today @themotleyfool #stocks $REGN $NTLA $EDIT $CRSP, This Healthcare Stock Could Keep Crushing the Market, Trump's COVID-19 Treatment: Here Are the Stocks of All the Drugmakers Involved, Pfizer, BioNTech, and Regeneron Hit With Patent Lawsuits Over COVID-19 Drugs and Vaccines, Why Regeneron Pharmaceuticals Shot 7% Higher on Monday, President Trump Received Regeneron's Experimental Antibody Treatment for COVID-19, Copyright, Trademark and Patent Information. If you continue to see this 50, während investierte Kapitalrenditen es schafften, – 28. M mit durchschnittlichem Handelsvolumen von 945. as we grow and there is an effort to listen to what employees have to say.
Blazer Ticket Office, Construct Synonym, Eight Days A Week, Facts About Jesus' Birth, Roy Bryant Children, Langara Apartments For Rent, Mystery Men,